In the U.S., 70% of adults are either obese or overweight, and over 30 million have Type 2 diabetes1. A new drug, Mounjaro (tirzepatide), is bringing new hope against obesity. In tests, Mounjaro helped people lose up to 21% of their weight. On average, people lost 12 pounds more than those taking semaglutide (Ozempic)1.
Key Takeaways
- Mounjaro, a new dual-receptor agonist, has shown great weight loss results in trials.
- The FDA is quickly reviewing Mounjaro for weight loss because there are few treatments for obesity.
- Mounjaro mimics hormones that control glucose levels, reduce hunger, and slow digestion.
- Patients might need to take Mounjaro for a long time to keep off the weight.
- Getting insurance to cover Mounjaro for weight loss can be hard because it’s not yet FDA-approved for this.
What is Mounjaro?
Mounjaro: A New Medication for Weight Management
Mounjaro is a new injectable drug approved by the FDA for type 2 diabetes treatment2. It works by activating two key receptors in the body. The FDA has fast-tracked it for weight loss, showing its potential as a weight management tool2.
FDA Approval and Fast Track Designation
In November 2023, the FDA approved Mounjaro for adults with obesity or overweight2. This came after it got a Fast Track designation for its quick review due to its potential in obesity treatment2.
“Mounjaro’s FDA approval for chronic weight management is a significant milestone in the treatment of obesity, which affects a large portion of the U.S. population. This dual-receptor agonist has demonstrated impressive weight loss results in clinical trials, offering a new option for individuals struggling with excess weight and associated health conditions.”
About 70% of American adults are overweight or obese, often with related health issues2. Losing 5% to 10% of body weight through diet and exercise can lower the risk of heart disease for those with obesity or overweight2.
| Medication | Average Weight Loss |
|---|---|
| Mounjaro 5mg weekly | 16.1 kg (35.5 lb)3 |
| Mounjaro 10mg weekly | 22.2 kg (48.9 lb)3 |
| Mounjaro 15mg weekly | 23.6 kg (52.0 lb)3 |
| Placebo | 2.4 kg (5.3 lb)3 |
Clinical trials show Mounjaro’s effectiveness in weight loss. Obese or overweight individuals with Type 2 diabetes lost up to 15% of their weight. Those without diabetes lost almost a quarter of their body weight4. Mounjaro was more effective than other drugs in helping patients reach weight loss goals423.
How Does Mounjaro Work for Weight Loss?
Mounjaro is a new weight loss drug that uses a special way to help people lose weight5. It works by acting on two receptors in the body at the same time. This makes it more effective than some other drugs that only work on one receptor5.
Dual-Receptor Agonist: Activating GLP-1 and GIP
Mounjaro’s success comes from working on two important receptors, GLP-1 and GIP5. GLP-1 helps control hunger and blood sugar levels. GIP is key for managing glucose and energy balance6. By working on both receptors, Mounjaro starts a chain of events that leads to lasting weight loss.
Mechanisms of Action: Appetite Suppression and Slower Gastric Emptying
When Mounjaro works on the GLP-1 and GIP receptors, it does two main things to help with weight loss5. It makes users feel full for longer, which means they eat less6. It also slows down how fast food leaves the stomach, keeping you feeling full longer5. These effects together help Mounjaro work well for weight loss.
For people struggling with obesity, Mounjaro is a helpful option when diet and exercise aren’t enough56. Its unique way of working makes it a strong choice for managing weight.
“Mounjaro has been shown to significantly lower weight in people with obesity, with higher doses associated with even more weight loss.”5
| Medication | Mechanism of Action | Weight Loss Potential |
|---|---|---|
| Mounjaro (Tirzepatide) | Dual-receptor agonist (GLP-1 and GIP) | Significant weight loss, up to 35 pounds in clinical trials57 |
| Ozempic (Semaglutide) | GLP-1 receptor agonist | Moderate weight loss, up to 15% of body weight5 |
| Wegovy (Semaglutide) | GLP-1 receptor agonist | Moderate weight loss, up to 15% of body weight5 |
Clinical Trials and Effectiveness
Clinical trials show Mounjaro is effective for weight loss. In one study, patients on the highest dose lost 18% of their weight on average8. Another trial with type 2 diabetes patients showed a 12% weight loss with the 15 mg dose8. These results are better than other weight loss drugs like Ozempic and Wegovy.
Unprecedented Weight Loss Results
Recent studies highlight Mounjaro’s weight loss success. A meta-analysis of 10 studies with 9,873 patients found Mounjaro led to a -9.81 kg weight loss8. This was more than the placebo, GLP-1 RAs, and insulin groups. The study showed all Mounjaro doses (5 mg, 10 mg, and 15 mg) were more effective than the others8.
Comparison with Ozempic and Wegovy
Studies haven’t directly compared Mounjaro to Ozempic or Wegovy, but it seems Mounjaro might be better. A study found Mounjaro helped people with type 2 diabetes lose more weight than Ozempic9. Another trial showed an average weight loss of 24.2% over 11 months, with some losing 58 pounds10. Yet, more research is needed to compare it to other medications.
Mounjaro’s clinical trials show it could be a top choice for weight loss. With obesity on the rise, affecting nearly a quarter of the world by 203510, Mounjaro could be key in fighting this health issue8910.
mounjaro weight loss
Mounjaro got the green light from the FDA in 2022 for type 2 diabetes treatment11. Now, it’s being used off-label for weight loss too. This injectable drug is stronger than Ozempic because it works on two receptors11. It helps control hunger, makes you feel full sooner, and cuts down on calories, leading to weight loss11.
Starting with 2.5 mg a week, you can increase the dose by 2.5 mg every four weeks until you hit 15 mg11. You inject it under the skin, usually in the belly or thigh, on the same day every week11.
Studies show Mounjaro beats Ozempic in weight loss12. It made patients three times more likely to lose 15% of their weight, and more likely to lose 10% or 5%12. After a year, those on Mounjaro lost an average of 15.2% of their weight, while Ozempic users lost 7.9%12.
Even though Mounjaro isn’t FDA-approved for weight loss, doctors use it for this purpose11. Wegovy is FDA-approved for weight loss in overweight adults11. If you’re thinking about Mounjaro for weight loss, talk to your doctor about the risks and benefits.
To sum up, Mounjaro for weight loss starts at 2.5 mg weekly, going up to 15 mg11. It’s more effective than Ozempic for losing weight, making it a popular choice for those fighting obesity111213.
Potential Side Effects and Precautions
Mounjaro is a new weight loss drug that has shown great results. But, it’s important to know about its possible side effects and safety steps14. It might cause mild side effects like nausea, diarrhea, and less appetite15. You might also experience indigestion, vomiting, constipation, gas, bloating, heartburn, and mild allergic reactions16. These issues usually go away in a few days or weeks after starting the treatment or adjusting the dose.
Common Side Effects: Gastrointestinal Issues
Gastrointestinal problems are a common side effect of Mounjaro14. Serious issues can include severe digestive problems, like kidney damage, pancreatitis, and gallbladder issues15. Dehydration from nausea, vomiting, and diarrhea can also lead to kidney problems16. Although rare, some people in clinical trials experienced acute pancreatitis, a serious condition.
Warnings and Contraindications
There are important warnings and things to avoid with Mounjaro14. The FDA warns about a higher risk of thyroid cancer from animal studies15. It’s not recommended for people with a history of thyroid cancer or certain genetic conditions16. Also, a small number of people may have severe allergic reactions.
It’s crucial for patients to tell their doctors about any side effects, no matter how small16. This helps improve our understanding of Mounjaro’s safety and better patient care.
Long-Term Use and Weight Maintenance
Using weight loss medications like Mounjaro often means you need to keep taking them to keep the weight off. Studies show that if you stop these medications, like Ozempic and Wegovy, you might gain back the weight you lost17. These medications can be expensive, even with insurance, which might stop some people from continuing their treatment17.
Continuous Treatment for Sustained Weight Loss
Researchers are looking into if using Mounjaro for a long time can help keep weight off. It seems that to keep the weight off, you might need to keep taking the medication18. In a study, people who kept taking tirzepatide, the active part of Mounjaro, for another year kept losing weight. Those who stopped taking it gained back some of their weight18.
It’s also key to exercise regularly, at least 30 minutes a day, five times a week, to help keep weight off, with or without medication17. If you stop taking these drugs, it’s important to get support from health experts, like dietitians who focus on weight acceptance17.
After stopping medication, eating foods high in fiber and protein is advised. It’s also good to spread out your protein intake and include foods like legumes, whole grains, leafy greens, and healthy fats in your diet17. You might also look into other treatments, like endoscopic bariatric procedures, based on your needs17.
It’s vital to keep treating any health issues linked to obesity, like high blood pressure and type 2 diabetes, even after stopping weight loss medication17. It’s important to have realistic goals for keeping weight off after stopping medication. Remember, it’s common to gain weight back, and strict dieting can be harmful17.
In summary, using Mounjaro for a long time seems to be key to keeping weight off, similar to other medications like it18. Stopping the medication often leads to weight gain, showing the need for ongoing treatment and a full approach to managing weight181719.
Cost and Accessibility
Mounjaro, a new drug for weight management, can be expensive for many people. It was approved by the FDA in November 202320. The cost for a month of Mounjaro can be between $1,000 to $1,200, depending on where you are and how much you need20.
Even though Mounjaro helps with weight loss, its high price can be a problem for some20. Those without insurance might find it hard to afford. Looking into financial help, discounts, or savings plans is key20. But, insurance often only covers Mounjaro for type 2 diabetes, not weight loss20.
Insurance Coverage and Affordability Challenges
Insurance can make Mounjaro cheaper for people with Medicare, Medicaid, or certain commercial plans21. Discounts from the maker, like the Mounjaro Savings Card, can also help. This could bring the monthly cost down to as little as $2521.
Even with these options, some might still struggle to get Mounjaro because of its cost or shortages20. Starting with a small dose and drinking plenty of water can ease side effects like nausea and diarrhea20. If you have low blood sugar or dehydration, talk to your doctor right away20.
As more people look for ways to manage their weight, making Mounjaro more affordable and accessible is key20. Research and new developments might make it easier to get in the future202122.
Pros and Cons of Mounjaro for Weight Loss
Mounjaro, also known as tirzepatide, has helped many people with obesity and type 2 diabetes lose weight23. But, like any treatment, it has its good and bad points to think about.
Advantages of Mounjaro for Weight Loss
- Remarkable weight loss results: In tests, people taking Mounjaro lost up to 20.9% of their body weight23.
- Effective for both obesity and type 2 diabetes: A study of nearly 10,000 people showed Mounjaro works well for weight loss in those with type 2 diabetes and obesity23.
- Dual-receptor agonist mechanism: Mounjaro works on two receptors, GLP-1 and GIP, which helps it reduce hunger and aid in weight loss better than some other treatments23.
Potential Drawbacks of Mounjaro for Weight Loss
- High cost and limited insurance coverage: Mounjaro can be expensive, costing from $25 a month with insurance to over $1,000 without24.
- Gastrointestinal side effects: Side effects include nausea, vomiting, diarrhea, constipation, and stomach pain23.
- Serious potential side effects: Rare but serious issues like pancreatitis, low blood sugar, and thyroid tumors or cancer have been linked to Mounjaro23.
- Continuous long-term use required: To keep losing weight, you might need to take Mounjaro forever, as stopping it could lead to weight gain24.
Mounjaro has shown great results in weight loss, especially for those with obesity and type 2 diabetes232524. But, the high cost, possible side effects, and need for ongoing use are things to consider when looking at its benefits and drawbacks.
“Mounjaro is a game-changer in the world of weight loss medications, but it’s important to weigh the potential benefits against the risks and costs for each individual patient.”
Comparing Mounjaro with Other Weight Loss Medications
Similarities and Differences with Ozempic and Wegovy
There’s been a big change in weight loss drugs, with many new options now available26. Mounjaro, Ozempic, and Wegovy are leading the way in treating obesity and type 2 diabetes. They’ve changed how we think about these health issues.
Mounjaro, Ozempic, and Wegovy all work on GLP-1 receptors but differ in how they work. Mounjaro targets both GLP-1 and GIP receptors, while Ozempic and Wegovy focus on GLP-1 only27. This makes Mounjaro better at losing weight28.
| Medication | Active Ingredient | Receptor Agonist | Weight Loss Results |
|---|---|---|---|
| Mounjaro (Tirzepatide) | Tirzepatide | Dual GLP-1 and GIP receptor agonist | Patients lost an average of 21.8 kg (48 lb) or 21% of their body weight at the highest dose28. Patients with type 2 diabetes lost an average of 5.5 kg (12 lb) to 11 kg (25 lb) over 52-weeks28. |
| Ozempic (Semaglutide) | Semaglutide | GLP-1 receptor agonist | Resulted in a 6% to 7% weight loss in adults with type 2 diabetes28. |
| Wegovy (Semaglutide) | Semaglutide | GLP-1 receptor agonist | Patients lost an average of 15% of their body weight28. Yielded an average 15% weight loss in adults and a 16.1% decrease in body mass index in children aged 12 years and older28. |
Studies are still looking into how safe and effective these drugs are for weight loss over time. But, Mounjaro seems to be better at losing weight than Ozempic and Wegovy because it works on two receptors27.
Even though these drugs work well, getting them can be hard because they’re expensive26. This is a big problem, especially in poor areas. Also, there have been shortages, making it hard to get them. This has led some people to buy them online without a doctor’s advice26.
The search for new weight loss drugs is ongoing. With new options like retatrutide and CagriSema coming up, we hope to find better ways to manage weight and metabolic issues262827.
Patient Selection and Considerations
Deciding if Mounjaro is the right weight loss medication for you needs a careful talk with your doctor. Mounjaro is approved for adults with a BMI of 30 kg/m2 or more. It’s also for those with a BMI of 27 kg/m2 or more who have weight-related conditions like high blood pressure, type 2 diabetes, or high cholesterol29.
Your doctor will look at your medical history and current health when thinking about Mounjaro. They will also check the medications you’re on. This makes sure Mounjaro is safe and right for you29.
Factors for Determining Suitability
- Body Mass Index (BMI): Mounjaro is approved for adults with a BMI of 30 kg/m2 or greater (obesity) or a BMI of 27 kg/m2 or greater (overweight) with at least one weight-related condition.
- Existing Health Conditions: Your healthcare provider will consider any weight-related conditions, such as high blood pressure, type 2 diabetes, or high cholesterol, to ensure Mounjaro is an appropriate treatment.
- Current Medications: Your provider will review any other medications you are taking to check for potential interactions or contraindications with Mounjaro.
- Personal Medical History: Your overall health history, including any previous weight loss attempts or other medical conditions, will be taken into account.
Your healthcare provider will look at these factors to see if Mounjaro is right for you. They will create a plan tailored to your health and wellness goals29.
“Mounjaro is a promising new weight loss medication, but it’s essential to work closely with your healthcare provider to ensure it’s the best fit for your individual needs and circumstances.”
Choosing to use Mounjaro for weight loss should be a team effort between you and your healthcare provider. By looking at your suitability, you can make a well-informed choice. This way, you can start a successful weight management journey with Mounjaro2930.
Future Research and Developments
Mounjaro is becoming a key player in weight loss medicine. Researchers are looking into its long-term effects and future improvements31. They want to see if the weight loss lasts after stopping the drug31. They also aim to mix Mounjaro with other treatments to make it work better31.
Ongoing Studies and Potential Advancements
Scientists are exploring Mounjaro’s potential. They might find new ways to use it or improve it31. With obesity seen as a disease32, and drugs like Mounjaro available, the future looks bright for weight loss32.
| Mounjaro Clinical Trials | Weight Loss Results |
|---|---|
| SURMOUNT-1 | Obese individuals with underlying conditions lost up to 21% of body weight after 72 weeks33 |
| SURMOUNT-2 | Obese Type 2 diabetics lost up to 15% of body weight after 72 weeks33 |
| SURMOUNT-3 | Individuals who had already lost 5% of body weight lost an average of 21% after 72 weeks33 |
| SURMOUNT-4 | Participants lost 21% initially, then regained 15% when taken off the drug, while those who stayed on lost 7% more33 |
The need for good weight loss solutions is growing. Pharmaceutical companies are working hard to improve32. Eli Lilly has a new obesity treatment doing well in tests, and they’re also making an oral form33. Novo Nordisk made $14.2 billion from GLP-1 drugs in 2022, and they expect sales to hit $90 billion soon33.
These studies and new developments in weight management medicines like Mounjaro are exciting. They offer hope for people looking for lasting weight loss solutions313233.
Conclusion
Mounjaro is a new weight loss drug that has shown great results in clinical tests. It works better than other weight loss drugs. Its special way of working targets two key hormones that help control hunger and sugar levels. This is why it’s so effective at losing weight34.
The weight loss seen with Mounjaro is impressive, even for people with long-term obesity or type 2 diabetes3435. It could become a key tool for managing weight and obesity. Even people without diabetes have lost a lot of with it36.
More research is needed, but Mounjaro could play a big role in fighting obesity. It’s important to think about possible side effects and long-term use36. But the results from tests show it could be a big help in tackling the obesity problem34.
FAQ
What is Mounjaro?
Mounjaro (tirzepatide) is a new drug approved for chronic weight management in adults. It’s for those with a BMI of 30 kg/m2 or more, or a BMI of 27 kg/m2 or more with weight-related conditions. It works by activating hormones in the intestine to reduce hunger and food intake.
How does Mounjaro work for weight loss?
Mounjaro is a dual-receptor agonist. It activates the GLP-1 and GIP receptors in the intestine. This approach is more effective for weight loss than single-receptor medications. By doing this, Mounjaro lowers hunger and slows stomach emptying. This makes you feel full and eat less, leading to weight loss.
What are the weight loss results with Mounjaro?
Clinical trials show great results with Mounjaro. In one trial, patients on the highest dose lost 18% of their body weight. In another trial with type 2 diabetes patients, the 15 mg dose led to a 12% weight loss.
What is the typical dosage and administration of Mounjaro for weight loss?
The usual starting dose is 2.5 mg, given once a week under the skin. The dose can be increased by 2.5 mg every four weeks until reaching 15 mg. It’s injected in the abdomen or thigh, aiming for the same day each week.
What are the potential side effects and precautions with Mounjaro?
Side effects include nausea, diarrhea, vomiting, and stomach discomfort. It also has warnings for thyroid tumors, pancreatitis, and kidney injury. Other concerns include gallbladder problems, low blood sugar, and suicidal thoughts.
How long do patients need to use Mounjaro to maintain weight loss?
Patients likely need to keep using Mounjaro to keep losing weight. Studies show weight gain after stopping similar medications. Ongoing research looks into long-term use and maintaining weight loss with Mounjaro.
How does the cost and accessibility of Mounjaro affect its use for weight loss?
Mounjaro’s high cost and limited insurance coverage can make it hard to get. It’s mainly covered for type 2 diabetes, not weight loss. This, along with possible shortages, can limit access for many.
How does Mounjaro compare to other weight loss medications like Ozempic and Wegovy?
Mounjaro, Ozempic, and Wegovy are all GLP-1 and GIP receptor agonists. But Mounjaro targets both receptors, making it more effective for weight loss. This dual-action is thought to give Mounjaro an edge over the others.
Who is Mounjaro suitable for, and how do patients determine if it’s the right treatment?
Mounjaro is for adults with obesity or overweight and weight-related conditions. Talk to your doctor to see if it’s right for you, considering your health history and current medications.
What are the potential future developments and research for Mounjaro?
Research is ongoing to see if Mounjaro helps maintain weight loss over time. Studies also explore combining Mounjaro with other treatments for better results. Future advancements could improve its effectiveness and accessibility.
Source Links
- What is Mounjaro? And does it work better for weight loss than Ozempic and Wegovy? – https://www.uchealth.org/today/what-is-mounjaro-and-how-does-it-work-for-weight-loss/
- FDA Approves New Medication for Chronic Weight Management – https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
- Mounjaro for weight loss, does it work? How much will I lose? – https://www.drugs.com/medical-answers/mounjaro-work-weight-loss-3570665/
- Mounjaro leads to far more weight loss than Ozempic, real-world study finds – https://www.today.com/health/news/tirzepatide-mounjaro-weight-loss-drug-rcna82400
- Mounjaro: A Diabetes Med That’s Treating Obesity – https://health.clevelandclinic.org/mounjaro-for-weight-loss
- How Does Mounjaro Weight Loss Medication Work? – https://conciergemdla.com/blog/how-does-mounjaro-work/
- Mounjaro Weight Loss: How Tirzepatide Helps You Lose Weight – https://thebiostation.com/bioblog/mounjaro-weight-loss-how-tirzepatide-helps-you-lose-weight/
- Weight loss efficiency and safety of tirzepatide: A Systematic review – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159347/
- Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial – Nature Medicine – https://www.nature.com/articles/s41591-023-02597-w
- Beyond Ozempic: Trials Hold Promise of Highly Effective Obesity Drugs – https://medicine.yale.edu/news-article/beyond-ozempic-trials-hold-promise-for-highly-effective-obesity-drugs/
- Is Mounjaro® better for weight loss than Ozempic™? – https://www.nebraskamed.com/health/conditions-and-services/bariatrics-weight-loss/is-mounjaror-better-for-weight-loss-than
- Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real-world study says – https://www.cnbc.com/2023/11/27/mounjaro-superior-to-ozempic-for-weight-loss-study-says.html
- Average Weight Loss of 60 Pounds Reported in Mounjaro Trial – https://www.webmd.com/obesity/news/20231016/average-weight-loss-of-60-pounds-reported-mounjaro-trial
- Mounjaro: Mild and serious side effects – https://www.medicalnewstoday.com/articles/drugs-mounjaro-side-effects
- Mounjaro Side Effects: What They Are and How to Manage Them – https://www.healthline.com/health/drugs/mounjaro-side-effects
- Mounjaro Side Effects: What You Need to Know | eMed UK – https://www.emed.com/uk/blog/health/mounjaro-side-effects-what-you-need-to-know
- Ozempic, Wegovy, Mounjaro: How to Maintain Weight After Stopping – https://www.healthline.com/health-news/avoid-weight-gain-after-ozempic
- Tirzepatide Enhances Weight Loss with Sustained Treatment but Discontinuation Leads to Weight Regain – https://news.weill.cornell.edu/news/2023/12/tirzepatide-enhances-weight-loss-with-sustained-treatment-but-discontinuation-leads-to
- How Much Weight Comes Back After You Stop Using a Weight-Loss Drug? – https://www.nytimes.com/2023/12/11/well/tirzepatide-weight-gain-mounjaro.html
- Tirzepatide Cost: Pricing Breakdown for Weight Loss Patients | Dr. Brandon Richland, MD – https://www.richlandmd.com/cosmetic/tirzepatide-cost/
- How Much is Mounjaro Without Insurance? – https://www.medicalnewstoday.com/articles/how-much-is-mounjaro-without-insurance
- Over the Counter Mounjaro Alternatives: Your Guide to Easy and Accessible Options | OCNJ Daily – https://ocnjdaily.com/counter-mounjaro-alternatives-guide-easy-accessible-options/
- Mounjaro For Weight Loss: Safety, Side Effects And More – https://www.forbes.com/health/weight-loss/mounjaro-for-weight-loss/
- Mounjaro for Weight Loss: Health Experts Answer 9 Common Questions – https://www.healthline.com/health-news/health-experts-answer-9-common-questions-about-using-mounjaro-for-weight-loss
- The pros, cons, and unknowns of popular weight-loss drugs – https://hub.jhu.edu/2024/01/11/ozempic-wegovy-weight-loss-drugs-pros-cons/
- Ozempic and Mounjaro Aren’t the Same. Here’s How Weight-Loss Drugs Compare – https://www.scientificamerican.com/article/mounjaro-and-ozempic-arent-the-same-heres-how-weight-loss-drugs-compare/
- Wegovy vs. Mounjaro: How these drugs compare – https://www.medicalnewstoday.com/articles/drugs-wegovy-vs-mounjaro
- How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss? – https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/
- Switching from Wegovy to Mounjaro: How To Guide for Patients | eMed UK – https://www.emed.com/uk/blog/health/switching-from-wegovy-to-mounjaro-how-to-guide-for-patients
- Mounjaro for Weight Loss: Obesity Management Solutions | Dr. Brandon Richland, MD – https://www.richlandmd.com/cosmetic/mounjaro-for-weight-loss/
- The new weight-loss drugs and cancer – https://www.fredhutch.org/en/news/center-news/2024/03/the-new-weight-loss-drugs-and-cancer.html
- Weight loss drugs’ messy rise: How Ozempic, Wegovy, and Mounjaro really affect patients — and what comes next – https://www.businessinsider.com/weight-loss-glp-1-drugs-ozempic-wegovy-mounjaro-effects-future-2023-12
- Lilly adds to case for Mounjaro’s weight-loss benefits with new study data – https://www.biopharmadive.com/news/lilly-mounjaro-weight-loss-diet-exercise-stop-treatment/689192/
- Weight loss: Mounjaro, Zepbound can help people with long-term obesity – https://www.medicalnewstoday.com/articles/mounjaro-zepbound-can-help-with-weight-loss-in-people-with-long-term-obesity
- Users of diabetes drug Mounjaro lost more weight than those on Ozempic, large study finds | CNN – https://www.cnn.com/2023/11/28/health/mounjaro-ozempic-weight-loss-study/index.html
- Mounjaro for Weight Loss: Off-Label Use for Weight Management | Dr. Brandon Richland, MD – https://www.richlandmd.com/cosmetic/mounjaro-for-weight-loss-in-non-diabetics/